Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases

World Journal of Surgery

Volumn 24, Issue 7, 2000, Pages 797-810

  Good, Robert A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; GENE LOCUS; GENETIC MANIPULATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OSTEOCLAST; WHOLE BODY RADIATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION;

EID: 0033918590     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010128     Document Type: Conference Paper

References (106)

1. Good, R.A., Zak, S.J.: Disturbances in gammaglobulin synthesis as "experiments of nature." Pediatrics 18:109, 1956
2. DiGeorge, A.M.: Discussion (following presentation by M.D. Cooper). Perlman and Good. J. Pediatr. 67:908, 1965
3. Peterson, R.D.A., Cooper, M.D., Good, R.A.: The pathogenesis of immunologic deficiency diseases. Am. J. Med. 38:579, 1965
4. Cooper, M.D., Peterson, R.D.A., Good, R.A.: A new concept of the cellular basis of immunity. J. Pediatr. 67:907, 1965
5. Cooper, M.D., Peterson, R.D.A., Good, R.A.: Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 205:143, 1965
6. Cooper, M.D., Peterson, R.D.A., South, M.A., Good, R.A.: The functions of the thymus system and the bursa system in the chicken. J. Exp. Med. 123:75, 1966
7. Cooper, M.D., Perey, D.Y., Peterson, R.D.A., Gabrielsen, A.E., Good, R.A.: The two-component concept of the lymphoid system. Birth Defects 4:7, 1968
8. Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R., Good, R.A.: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366, 1968
9. Good, R.A.: Immunologic reconstitution: the achievement and its meaning. Hosp. Pract. 4:41, 1969
10. Good, R.A.: Progress toward a cellular engineering. (Lasker Award lecture). J.A.M.A. 214:1289, 1970
11. Gatti, R.A., Meuwissen, H.J., Terasaki, P.I., Good, R.A.: Recombination within the HLA-locus. Tissue Antigens 1:239, 1971
12. Good, R.A., Gatti, R.A., Hong, R., Meuwissen, H.J.: Successful marrow transplantation for correction of immunological deficit in lymphopenic agammaglobulinemia and treatment of immunologically induced pancytopenia. Exp. Hematol. 19:4, 1969
13. Gatti, R.A., Good, R.A.: Follow-up of correction of severe dual system immunodeficiency with bone marrow transplantation. J. Pediatr. 79:475, 1971
14. Onoé, K., Fernandes, G., Good, R.A.: Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J. Exp. Med. 151:115, 1980
15. Yasumizu, R., Sugiura, K., Iwai, H., Inaba, M., Makino, S., Ida, T., Imura, H., Hamashima, Y., Good, R.A., Ikehara, S.: Treatment of type I diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc. Natl. Acad. Sci. U.S.A. 84:6555, 1987
16. Iwai, H., Yasumizu, R., Sugiura, K., Inaba, M., Kumazawa, T., Good, R.A., Ikehara, S.: Successful pancreatic allografts in combination with bone marrow transplantation in mice. Immunology 62:457, 1987
17. Than, S., Ishida, H., Inaba, M., Fukuba, Y., Seino, Y., Adachi, M., Imura, H., Ikehara, S.: Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J. Exp. Med. 176:1233, 1992
18. Van Dooremall, J.C.: Albrecht von Graefes Arch. Clin. Exp. Ophthalmol. 19:359, 1873
19. Owen, R.D.: Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400, 1945
20. Anderson, D., Billingham, R.E., Lampkin, G.H., Medawar, P.B.: The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5:379, 1951
21. Streilein, J.W., Takeuchi, M., Taylor, A.W.: Immune privilege. T cell tolerance and tissue-restricted immunity. Hum. Immunol. 52:138, 1997
22. Griffith, T., Ferguson, T.A.: The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18:240, 1997
23. Uckan, D., Steele, A., Cherry, Wang, B.-Y., Chamizo, W., Koutsonikolis, A., Gilbert-Barness, E., Good, R.A.: Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3:655, 1997
24. Steele, A., Uckan, D., Steele, P., Chamizo, W., Washington, K., Koutsonikolis, A., Good, R.A.: RT in situ PCR for the detection of mRNA transcripts of Fas-L in the immune-privileged placental environment. Cell Vis. 5:13, 1998
25. Steele, A., Uckan, D., Chamizo, W., Ferre, P., Thomas, B., Edwards, T., Steele, P., Koutsonikolis, A., Good, R.A.: An optimized immunohistochemical protocol for both manual and automated staining of formalin fixed, paraffin embedded human placenta for demonstration and analyses of Fas, Fas-L and Bcl-2. J. Histotechnol. 21:285, 1998
26. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., Duke, R.C.: A role for CD95 ligand in preventing graft rejection. Nature 377:630, 1995
27. Streilein, J.W.: Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 9:236, 1995
28. Gao, Y., Herndon, J.M., Zhang, H., Griffith, T.S., Ferguson, T.A.: Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188:887, 1998
29. O'Connell, J., O'Sullivan, G.C., Collins, J.K., Shanahan, F.: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075, 1996
30. O'Connell, J., Bennett, M.W., O'Sullivan, G.C., Collins, J.K., Shanahan, F.: The Fas counterattack: cancer as a site of immune privilege. Immunol. Today 2:46, 1999
31. Rethy, L.A., Horvath, J.C., Sinkovics, J.G., Uckan, D., Steele, A., Horvath, E., Horak, A., Good, R.A.: Subversion of host immunity by human melanoma cells (HMC). I. FasL counterattack on lymphocytes [abstract 812]. A.A.C.R. Proc. 38:122, 1997
32. Ogata, H., Bradley, W.G., Inaba, M., Ogata, N., Ikehara, S., Good, R.A.: Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc. Natl. Acad. Sci. U.S.A. 92:5945, 1995
33. low. Proc. Natl. Acad. Sci. U.S.A. 94:2513, 1997
34. Mayumi, H., Good, R.A.: Dependency of cyclophosphamide-induced skin allogratt tolerance on age of adult recipient mice. Transplantation 46:451, 1988
35. Mayumi, H., Good, R.A.: Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J. Exp. Med. 169:213, 1989
36. Mayumi, H., Good, R.A.: The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice. Immunobiology 178:287, 1989
37. Mayumi, H., Good, R.A.: Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction. Immunobiology 179:86, 1989
38. Wang, B.-Y., El-Badri, N.S., Cherry, Good, R.A.: Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire MHC transplantation barrier in mice. Proc. Natl. Acad. Sci. U.S.A. 94:14632, 1997
39. Wang, B-Y., Cherry, El-Badri Dajani, N., Good, R.A.: Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation. Proc. Natl. Acad. Sci. U.S.A. 94:12065, 1997
40. Wang, B-Y., Yamamoto, Y., El-Badri-Dajani, N., and Good, R.A.: Treatment of autoimmune disease in BXSB mice by mixed bone marrow transplantation. Proc. Natl. Acad. Sci. U.S.A. 96:3012, 1999
41. Eisenberg, R.A., Izui, S., McConahey, P.J., Hang, L.M., Peters, C.J., Theofilopoulos, A.N., Dixon, F.J.: Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J. Immunol. 125:1032, 1980
42. Ildstad, S.T., Sachs, D.H., Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 37:168, 1984
43. Sardina, E.E., Sugiura, K., Ikehara, S., Good, R.A.: Transplantation of wheat germ agglutinin-positive hematopoietic cells to prevent or induce systemic autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 88:3218, 1991
44. El Badri, N.S., Wang, B-Y., Cherry, Good, R.A.: Osleoblasts promote engraftment of allogeneic hematopoietic stem cells. J. Exp. Hematol. 26:110, 1998
45. El-Badri, N.S., Wang, B.-Y., Steele, A., Cherry, Marikar, Y., Mizobe, K., Good, R.A.: Successful prevention of autoimmune disease by transplantation of adequate number of fully allogeneic hematopoietic stem cells. Transplantation, 2000 (In Press)
46. Mizutani, H., Engelman, R.W., Kinjoh, K., Kurata, Y., Ikehara, S., Good, R.A.: Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1 mice by hapoloidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies. Blood 82:3091, 1993
47. Lowenthal, R.M., Cohen, M.L., Atkinson, K., Biggs, J.C.: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J. Rheumatol. 20:137, 1993
48. Marmont, A.M.: Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?' Stem Cells 12:125, 1994
49. Eedy, D.J., Burrows, D., Bridges, J.M., Jones, F.G.: Clearance of severe psoriasis after allogeneic bone marrow transplantation. B.M.J. 300:908, 1990
50. Grau, J.M., Casademont, J., Monforte, R., Marin, P., Granena, A., Rozman, C., Urbano-Marquez, A.: Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transpl. 5:435, 1990
51. Melms, A., Faul, C., Sommer, N., Wietholter, H., Muller, C.A., Ehninger, G.: Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transpl. 9:78, 1990
52. Hagopian, W., Lemmark, A.: Autoimmune diabetes mellitus. In: The Autoimmune Diseases, vol. II, Rose, N.R., Mackay, I.R., editors. Sand Diego, Academic, 1992. pp. 235-278
53. Lampeter, E.F., Homberg, M., Quabeck, K., Schaffer, U.W., Wernet, P., Bertrams, J., Gross-Wilde, H., Gries, F.A., Kolb, H.: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243, 1993
54. Vialettes, B., Maraninchi, D., San Marco, M.P., Birg, F., Stoppa, A.M., Mattei-Zevaco, C., Thivolet, C., Heimitte, L., Vague, P., Mercier, P.: Autoimmune polyendocrine failure - type I (insulin-dependent) diabetes mellitus and hypothyroidism - after allogeneic bone marrow transplantation in a patient with lympoblastic leukaemia. Diabetologia 36:541, 1993
55. Holland, F.J., McConnon, J.K., Volpé, R., Saunders, E.F.: Concordant Graves' disease after bone marrow transplantation: implication for pathogenesis. J. Clin. Endocrinol. Metab. 72:837, 1991
56. Wyatt, D.T., Lum, L., Casper, J., Hunter, J., Camitta, B.: Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transpl. 5:357, 1990
57. Aldouri, M.A., Ruggier, R., Epstein, O., Prentice, H.G.: Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br. J. Haematol. 74:118, 1990
58. Ikehara, S., Takaku, F., Good, R.A., editors: Bone Marrow Transplantation - Basic and Clinical Studies. Tokyo, Springer, 1996
59. Van Bekkum, D.W.: Autologous stem cell therapy for treatment of autoimmune diseases. Exp. Hematol. 26:831, 1998
60. Van Gelder, M., Van Bekkum, D.W.: Effective treatment of experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 18:1029, 1996
61. Sharabi, Y., Sachs, D.H.: Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 169:493, 1989
62. Sharabi, Y., Aksentijevich. I., Sundt, T.M., III, Sachs, D.H., Sykes, M.: Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J. Exp. Med. 172:195, 1990
63. Lernmark, A.: Molecular biology of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:195, 1985
64. Marx, J.: Testing of autoimmune therapy begins. Science 252:272, 1991
65. Nakamura, T., Good, R.A., Inoue, S., Oo, M.M., Hamashima, Y., Ikehara, S.: Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 83:4529, 1986
66. DeFronzo, R.A., Bonadonna, R.C., Ferrannini, E.: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318, 1992
67. Foster, D.W., et al. Diabetes mellitus. In: Harrison's Principles of Internal Medicine, 14th ed., Fauci, A.S., Braunwald, E., Isselbacher, K.J., Wilson, J.D., Martin, J.B., Kasper, D.L., Hauser, S.L., Longo, D.L. editors. New York, McGraw-Hill, 1998. pp. 2060-2081
68. Batarseh, H., Thompson, R.A., Odugbesan, O., Barnett, A.H.: Insulin receptor antibodies in diabetes mellitus. Clin. Exp. Immunol. 71:85, 1988
69. Shimoyama, R., Fujita-Yamaguchi, Y., Boden, G.: Anti-insulin receptor antibodies in human diabetes. Diabetes Res. Clin. Pract. 7:559, 1989
70. Flier, J.S., Kahn, C.R., Roth, J., Bar, R.S.: Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63, 1975
71. Ross, R.: Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant. Proc. 25:2041, 1993
72. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801, 1993
73. Navab, M., Fogelman, A.M., Berliner, J.A., Territo, M.C., Demer, L.L., Frank, J.S., Watson, A.D., Edwards, P.A., Lusis, A.J.: Pathogenesis of atherosclerosis. Am. J. Cardiol. 76:18C, 1995
74. Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D., Lusis, A.J.: Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation 91: 2488, 1995
75. Libby, P., Sukhova, G., Lee, R.T., Galis, Z.S.: Cytokines regulate vascular functions related to stability of the atherosclerotic plaques. J. Cardiovasc. Pharmacol. 2:S9, 1995
76. Lutgens, E., Gorelik, L., Daemen, M.J.A.P., De Muinck, E.D., Grewal, I.S., Koteliansky, V.E., Flavell, R.A.: Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5:1313, 1999
77. Linton, M.F., Atkinson, J.B., Fazio, S.: Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267:1034, 1995
78. Takeda, T., Hosokawa, M., Takeshita, S., Irino, M., Higuchi, K., Matsushita, T., Tomita, Y., Yasuhira, K., Hamamoto, H., Shimizu, K., Ishii, M., Yamamuro, T.: A new murine model of accelerated senescence. Mech. Ageing Dev. 17:183, 1981
79. Hosokawa, M., Kasai, R., Higuchi, K., Takeshita, S., Shimizu, K., Hamamoto, H., Honma, A., Irino, M., Toda, K., Matsumura, A., Matshushita, M., Takeka, T.: Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech. Ageing Dev. 26:91, 1984
80. Hosokawa, M., Takeshita, S., Higuchi, K., Shimizu, K., Irino, M., Toda, K., Honma, A., Matsumura, A., Yasuhira, K., Takeda, T.: Cataract and other ophthalmic lesions in senescence accelerated mouse (SAM): morphology and incidence of senescence associated ophthalmic changes in mice. Exp. Eye Res. 38:105, 1984
81. Matsushita, M., Tsuboyama, T., Kasai, R., Okumura, H., Yamamuro, T., Higuchi, K., Higuchi, K., Kohno, A., Yonezu, T., Utani, A., Umezawa, M., Takeda, T.: Age-related changes in bone mass in the senescence-accelerated mouse (SAM): SAM-R/3 and SAM-P/6 as a new murine models for senile osteoporosis. Am. J. Pathol. 125:276, 1986
82. Takeshita, S., Hosokawa, M., Irino, M., Higuchi, K., Shimizu, K., Yasuhira, K., Takeda, T.: Mech. Ageing Dev. 20:13, 1982
83. Matsumura, A., Higuchi, K., Shimizu, K., Hosokawa, K., Yasuhira, K., Takeda, T.: Lab. Invest. 47:270, 1982
84. Higuchi, K., Matsumura, A., Honma, A., Takeshita, S., Hashimoto, K., Hosokawa, M., Yasuhira, K., Takeda, T.: Systemic senile amyloid in senescence-accelerated mice: A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab. Invest. 48:231, 1983
85. Kunisada, T., Higuchi, K., Aota, S., Takeda, T., Yamagishi, H.: Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). Nucleic Acids Res. 14:5729, 1986
86. Hosokawa, T., Hosono, M., Higuchi, K., Aoike, A., Kawai, K., Takeda, T.: Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline in immune activities of cultured spleen cells. Immunology 62:419, 1987
87. Hosokawa, T., Hosono, M., Hanada, K., Aoike, A., Kawai, K., Takeda, T.: Immune responses in newly developed short-lived SAM mice: Selectively impaired T-helper cell activity in vitro antibody response. Immunology 62:425, 1987
88. Yoshioka, H., Yoshida, H., Doi, T., Muso, E., Ohshio, G., Higuchi, K., Inada, M., Miyake, T., Kita, T., Hamashima, Y., Takeda, T. Autoimmune abnormalities in a murine model of accelerated senescence. Clin. Exp. Immunol. 75:129, 1989
89. Mariani, T., Martinez, C., Smith, J.M., Good, R.A.: Induction of immunological tolerance to male skin isografts in female mice subsequent to neonatal period. Proc. Soc. Exp. Biol. Med. 101:596, 1959
90. Martinez, C., Shapiro, F., Good, R.A.: Essential duration of parabiosis and development of tolerance to skin homografts in mice. Proc. Soc. Exp. Biol. Med. 104:256, 1960
91. Good, R.A.: Some historic milestones in development and employment of immunologic tolerance - a rather enduring personal history. In: Transplantation Tolerance Induction, Alexander, J.W., Good, R.A., editors, Austin, TX, Landes, 1996, pp. 11-41
92. Starzl, T.E., Machioro, T.L., Porter, K.A., Taylor, P.D., Faris, T.D., Herrmann, T.J., Hlad, C.J., Waddell, W.R.: Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog. Surgery 58:131, 1965
93. Kamada, N., Brons, G., Davies, H.F.F.S.: Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29:429, 1980
94. Cordier, G., Garnier, H., Clot, J.P., Campiez, P., Gortin, J.P., Clot, P.H., Rassinier, J.P., Nizza, M., Levy, R.: La greffe de foie orthotopique chez le pore. Mem. Acad. Chir. (Paris) 92:799, 1966
95. Calne, R.Y., White, H.J.O., Yoffa, D.E., Binns, R.M., Maginn, R.R., Herbertson, R.M., Millard, P.R., Molina, V.P., Davis, D.R.: Prolonged survival of liver transplants in the pig. B.M.J. 4:645, 1967
96. Porter, K.A.: Pathology of the orthotopic homograft and heterograft. In: Experience in Hepatic Transplantation, Starzl. T.E., editor. Philadelphia, Saunders, 1969, p. 427
97. Starzl, T.E., Demetris, A.J., Trucco, M., Murase, N., Ricordi, C., Idlstad, S., Ramos, H., Todo, S., Tzakis, A., Fung, J.J., Nalesnik, M., Zeevi, A., Rudert, W.A., Kocova, M.: Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptances. Hepatology 17:1127, 1993
98. Morita, H., Sugiura, K., Inaba, M., Jin, T., Ishikawa, J., Lian, Z., Adachi, Y., Sogo, S., Yamanishi, K., Taki, H., Adachi, M., Noumi, T., Kamiyama, Y., Good, R.A., Ikehara, S.: A new strategy for organ allografts without using immunosuppressants and irradiation. Proc. Natl. Acad. Sci. U.S.A. 95:6947, 1998
99. Sugiura, K., Pahwa, S., Yamamoto, Y., Borisov, K., Pahwa, R., Nelson, Jr., R.P., Ishikawa, J., Iguchi, T., Oyaizu, N., Good, R.A., Ikehara, S.: Characterization of natural suppressor cells in human bone marrow. Stem Cells 16:99, 1998
100. Gorczynski, R.M., Wojcik, D.: A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after anti-Ben-specific pretransplant immunization or transfusion. J. Immunol 152:2011, 1994
101. Hisha, H., Nishino, T., Kawamura, M., Adachi, S., Ikehara, S.: Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp. Hematol. 23:347, 1995
102. Ishida, T., Inaba, M., Hisha, H., Sugiura, K., Adachi, Y., Nagata, N., Ogawa, R., Good, R.A., Ikehara, S.: Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune diseases in MRL/lpr mice by transplantation of bone marrow plus bone (stromal cells) from the same donor. J. Immunol. 152:3119, 1994
103. Himeno, K., Good, R.A.: Marrow transplantation from tolerant donors to treat and prevent autoimmune diseases in BXSB mice. Proc. Natl. Acad. Sci. U.S.A. 85:2235, 1988
104. Puck, J.M., Straus, S.E., Le Deist, F., Rieux-Laucat, F., Fischer, A.: Inherited disorders with autoimmunity and defective lymphocyte regulation. In: Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, Ochs, H.D., Smith, C.I.E., Puck, J.M., editors. New York, Oxford University Press, 1999, pp. 339-352
105. Nagler, A., Ackerstein, A., Kapelushnik, J., Or, R., Naparstek, E., Slavin, S.: Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant 24:339, 1999
106. Hosaka, N., Nose, M., Kyogoku, M., Nagata, N., Miyashima, S., Good, R.A., Ikehara, S.: Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice. Proc. Natl. Acad. Sci. U.S.A. 93:8558, 1996